HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CIR To Present Draft Report On Infant Skin At June Meeting

This article was originally published in The Rose Sheet

Executive Summary

Cosmetic Ingredient Review’s Infant Resource Document provides the organization’s perspective on neonatal and infant skin and chemical absorption risks to guide the CIR Expert Panel’s future reviews and development of related reports. Generally, the group believes the stratum corneum is an effective barrier in infants at or around birth, but infants’ ability to metabolize chemicals versus that of adults is not as well understood, according to the draft document, which the panel will review at its meeting in June.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019051

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel